H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart

2007 ◽  
Vol 56 (3) ◽  
pp. 317-322 ◽  
Author(s):  
Beshay N.M. Zordoky ◽  
Ayman O.S. El-Kadi
1996 ◽  
Vol 24 (4) ◽  
pp. 581-587
Author(s):  
Cristiana Zanetti ◽  
Arrnalaura Stammati ◽  
Orazio Sapora ◽  
Flavia Zucco

The aim of this study was to investigate the endpoints related to cell death, either necrosis or apoptosis, induced by four chemicals in the promyelocytic leukemia cell line, HL-60. Cell morphology, DNA fragmentation, cytofluorimetric analysis and oxygen consumption were used to classify the type of cell death observed. In our analysis, we found that not all the selected parameters reproduced the differences observed in the cell death caused by the four chemicals tested. As cell death is a very complex phenomenon, several factors should be taken into account (cell type, exposure time and chemical concentration), if chemicals are to be classified according to differences in the mechanisms more directly involved in cell death.


2013 ◽  
Vol 63 (4) ◽  
pp. 493-503 ◽  
Author(s):  
Tiam Feridooni ◽  
Chris Mac Donald ◽  
Di Shao ◽  
Pollen Yeung ◽  
Remigius U. Agu

Abstract To investigate potential prevention or attenuation of anti- cancer drug induced cardiotoxicity using anti-ischemic drugs, a rat myoblast (H9c2) cell line was used as our in vitro cardiac model. Irinotecan and doxorubicin were found to be cytotoxic for the H9c2 cell line with IC50 of 30.69 ± 6.20 and 20.94 ± 6.05 mmol L-1, respectively. 5-Flurouracil and cladribine were not cytotoxic and thus IC50 could not be calculated. When 100 mmol L-1 doxorubicin was incubated for 72 hours with 50 mmol L-1 diltiazem, 100 mmol L-1 dexrazoxane and 100 mmol L-1 losartan, respectively, there was a 58.7 ± 10.2, 52.2 ± 11.7 and 44.7 ± 5.4 % reduction in cell death. When 200 mmol L-1 irinotecan was incubated for 72 hours with 100 mmol L-1 dexrazoxane, losartan and diltiazem, respectively, a 27.7 ± 6.9, 25.6 ± 5.1, and 19.1 ± 2.3 % reduction in cell death was observed. Our data suggests that losartan and diltiazem were as effective as dexrazoxane in protecting the cells against irinotecan- and doxorubicin-induced cell toxicity. These findings offer potential uses of anti- -ischemic drugs for ablation of cytotoxicity in response to mitochondrial injury, thereby improving patient outcomes and reducing health-care costs.


2016 ◽  
Vol 53 ◽  
pp. 74
Author(s):  
Claudio Alvarez ◽  
Paula Santana ◽  
Francisco Donoso ◽  
Felipe Ramírez ◽  
Jimena Cortés ◽  
...  

2020 ◽  
Vol 140 ◽  
pp. 111331 ◽  
Author(s):  
Diomira Luongo ◽  
Lucia Treppiccione ◽  
Francesco Maurano ◽  
Mauro Rossi ◽  
Paolo Bergamo
Keyword(s):  

2020 ◽  
Vol 8 (2) ◽  
pp. 1748459 ◽  
Author(s):  
Grace C. Lin ◽  
Tamara Leitgeb ◽  
Alexandra Vladetic ◽  
Heinz-Peter Friedl ◽  
Nadine Rhodes ◽  
...  

1992 ◽  
Vol 153 (3) ◽  
pp. 437-449 ◽  
Author(s):  
Jeffrey Bauer ◽  
Michael Margolis ◽  
Clara Schreiner ◽  
Cora-Jean Edgell ◽  
Jane Azizkhan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document